Because monoallelic mutation of the PALB2 gene is associated with an approximately six-fold increased risk of breast cancer in female patients [39,45–47], National Comprehensive Cancer Network guidelines recommend an annual mammogram and breast magnetic resonance imaging for mutation carriers of PALB2 [48]. The gene discussed is PALB2; the disease is breast cancer.